Growth Metrics

Quantum Genesis AI (QTZM) EPS (Basic) (2016 - 2026)

Quantumzyme's EPS (Basic) history spans 7 years, with the latest figure at -$0.11 for Q1 2026.

  • For Q1 2026, EPS (Basic) fell 12407.21% year-over-year to -$0.11; the TTM value through Jan 2026 reached -$99.84, up 23.81%, while the annual FY2025 figure was -$0.01, 0.39% changed from the prior year.
  • EPS (Basic) reached -$0.11 in Q1 2026 per QTZM's latest filing, up from -$99.74 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.0 in Q1 2025 to a low of -$131.05 in Q4 2024.
  • Average EPS (Basic) over 3 years is -$57.72, with a median of -$49.92 recorded in 2025.
  • Peak YoY movement for EPS (Basic): rose 23.89% in 2025, then crashed 12407.21% in 2026.
  • A 3-year view of EPS (Basic) shows it stood at -$131.05 in 2024, then grew by 23.89% to -$99.74 in 2025, then skyrocketed by 99.89% to -$0.11 in 2026.
  • Per Business Quant, the three most recent readings for QTZM's EPS (Basic) are -$0.11 (Q1 2026), -$99.74 (Q4 2025), and -$0.0 (Q1 2025).